Stay updated on Canakinumab Adjuvant Therapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Canakinumab Adjuvant Therapy in Lung Cancer Clinical Trial page.

Latest updates to the Canakinumab Adjuvant Therapy in Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check10 days agoChange DetectedA sitewide NIH notice announces a website terminology transition and links to updates and FAQs. It does not change the study information shown on the page.SummaryDifference1%

- Check17 days agoChange DetectedThe revision identifier in the footer changed from v3.7.1 to v3.7.2 on the otherwise unchanged 403 error page.SummaryDifference0.2%

- Check24 days agoChange DetectedThe ClinicalTrials.gov study page remains a 403 Forbidden error page; its footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check45 days agoChange DetectedAccess to the study record now yields a 403 Forbidden page with a simple header and footer. The full study content is no longer shown, indicating restricted access rather than the previous detailed trial information.SummaryDifference18%

- Check66 days agoChange DetectedThe page now includes an NIH grant/contract identifier as part of the study's external identifiers, and the revision version has been updated to v3.6.6.SummaryDifference0.0%

Stay in the know with updates to Canakinumab Adjuvant Therapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Canakinumab Adjuvant Therapy in Lung Cancer Clinical Trial page.